ONTOLOGY	ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
KEGG	hsa00640	Propanoate metabolism	3/120	32/8135	0.01137	0.9219	0.9219	PCCA/LDHAL6B/LDHA	3
KEGG	hsa05014	Amyotrophic lateral sclerosis	11/120	364/8135	0.01829	0.9219	0.9219	PSMA7/ATG14/TUBB3/UQCRFS1/NUP62/PIK3C3/SOD1/TANK/MAP3K5/NXT2/NDUFA3	11
KEGG	hsa04622	RIG-I-like receptor signaling pathway	4/120	70/8135	0.01956	0.9219	0.9219	ISG15/IFNW1/TANK/IRF7	4
KEGG	hsa04145	Phagosome	6/120	152/8135	0.02468	0.9219	0.9219	TUBB3/SFTPA2/THBS1/PIK3C3/SCARB1/CD14	6
KEGG	hsa00450	Selenocompound metabolism	2/120	17/8135	0.0254	0.9219	0.9219	TXNRD3/SEPHS2	2
KEGG	hsa00620	Pyruvate metabolism	3/120	47/8135	0.03171	0.9219	0.9219	LDHAL6B/ALDH3A2/LDHA	3
KEGG	hsa04979	Cholesterol metabolism	3/120	50/8135	0.03714	0.9219	0.9219	SCARB1/NPC2/ANGPTL4	3
KEGG	hsa05225	Hepatocellular carcinoma	6/120	168/8135	0.03767	0.9219	0.9219	SMARCA2/GAB1/GSTM3/FZD1/TXNRD3/WNT10B	6
KEGG	hsa05022	Pathways of neurodegeneration - multiple diseases	12/120	476/8135	0.04763	0.9219	0.9219	PSMA7/ATG14/TUBB3/UQCRFS1/PIK3C3/SOD1/FZD1/TANK/MAP3K5/WNT10B/SNCA/NDUFA3	12
KEGG	hsa05010	Alzheimer disease	10/120	384/8135	0.05677	0.9219	0.9219	PSMA7/ATG14/TUBB3/UQCRFS1/PIK3C3/FZD1/MAP3K5/WNT10B/SNCA/NDUFA3	10
KEGG	hsa04140	Autophagy - animal	5/120	141/8135	0.05713	0.9219	0.9219	RRAGB/ATG14/RRAGD/PIK3C3/TANK	5
KEGG	hsa00630	Glyoxylate and dicarboxylate metabolism	2/120	30/8135	0.07181	0.9219	0.9219	PCCA/HYI	2
KEGG	hsa05131	Shigellosis	7/120	247/8135	0.07235	0.9219	0.9219	RRAGB/ATG14/RRAGD/PIK3C3/FBXW11/CD14/CALCOCO2	7
KEGG	hsa00010	Glycolysis / Gluconeogenesis	3/120	67/8135	0.07602	0.9219	0.9219	LDHAL6B/ALDH3A2/LDHA	3
KEGG	hsa04150	mTOR signaling pathway	5/120	156/8135	0.08047	0.9219	0.9219	RRAGB/RRAGD/FZD1/MIOS/WNT10B	5
KEGG	hsa05204	Chemical carcinogenesis - DNA adducts	3/120	69/8135	0.08144	0.9219	0.9219	GSTM3/HSD11B1L/SULT1A2	3
KEGG	hsa05016	Huntington disease	8/120	306/8135	0.08224	0.9219	0.9219	PSMA7/ATG14/TUBB3/UQCRFS1/PIK3C3/SOD1/MAP3K5/NDUFA3	8
KEGG	hsa05230	Central carbon metabolism in cancer	3/120	70/8135	0.08421	0.9219	0.9219	LDHAL6B/LDHA/RET	3
KEGG	hsa01524	Platinum drug resistance	3/120	73/8135	0.09276	0.9219	0.9219	GSTM3/MSH2/MAP3K5	3
KEGG	hsa05012	Parkinson disease	7/120	266/8135	0.09786	0.9219	0.9219	PSMA7/TUBB3/UQCRFS1/SOD1/MAP3K5/SNCA/NDUFA3	7
KEGG	hsa05417	Lipid and atherosclerosis	6/120	215/8135	0.09789	0.9219	0.9219	CD14/CYP2J2/NOS3/TANK/IRF7/MAP3K5	6
KEGG	hsa05340	Primary immunodeficiency	2/120	38/8135	0.1077	0.9219	0.9219	JAK3/ORAI1	2
KEGG	hsa04142	Lysosome	4/120	132/8135	0.1305	0.9219	0.9219	AP1B1/LAMP3/NPC2/AGA	4
KEGG	hsa05418	Fluid shear stress and atherosclerosis	4/120	139/8135	0.1492	0.9219	0.9219	RAC3/GSTM3/NOS3/MAP3K5	4
KEGG	hsa00130	Ubiquinone and other terpenoid-quinone biosynthesis	1/120	11/8135	0.1509	0.9219	0.9219	VKORC1L1	1
KEGG	hsa00280	Valine, leucine and isoleucine degradation	2/120	48/8135	0.1575	0.9219	0.9219	PCCA/ALDH3A2	2
KEGG	hsa04550	Signaling pathways regulating pluripotency of stem cells	4/120	143/8135	0.1603	0.9219	0.9219	JAK3/LEFTY1/FZD1/WNT10B	4
KEGG	hsa05017	Spinocerebellar ataxia	4/120	143/8135	0.1603	0.9219	0.9219	PSMA7/ATG14/PIK3C3/MAP3K5	4
KEGG	hsa04350	TGF-beta signaling pathway	3/120	94/8135	0.1613	0.9219	0.9219	THBS1/LEFTY1/GREM2	3
KEGG	hsa00510	N-Glycan biosynthesis	2/120	50/8135	0.168	0.9219	0.9219	RPN2/GANAB	2
KEGG	hsa00270	Cysteine and methionine metabolism	2/120	51/8135	0.1732	0.9219	0.9219	LDHAL6B/LDHA	2
KEGG	hsa00330	Arginine and proline metabolism	2/120	51/8135	0.1732	0.9219	0.9219	ALDH3A2/NOS3	2
KEGG	hsa04913	Ovarian steroidogenesis	2/120	51/8135	0.1732	0.9219	0.9219	SCARB1/CYP2J2	2
KEGG	hsa04640	Hematopoietic cell lineage	3/120	99/8135	0.1794	0.9219	0.9219	CD7/CD14/ITGA3	3
KEGG	hsa04934	Cushing syndrome	4/120	155/8135	0.1954	0.9219	0.9219	SCARB1/FZD1/ORAI1/WNT10B	4
KEGG	hsa04620	Toll-like receptor signaling pathway	3/120	104/8135	0.1981	0.9219	0.9219	CD80/CD14/IRF7	3
KEGG	hsa04390	Hippo signaling pathway	4/120	157/8135	0.2014	0.9219	0.9219	PRKCI/FBXW11/FZD1/WNT10B	4
KEGG	hsa04370	VEGF signaling pathway	2/120	59/8135	0.2161	0.9219	0.9219	RAC3/NOS3	2
KEGG	hsa05165	Human papillomavirus infection	7/120	331/8135	0.2163	0.9219	0.9219	ISG15/PRKCI/THBS1/FZD1/ITGA3/WNT10B/HEY2	7
KEGG	hsa04066	HIF-1 signaling pathway	3/120	109/8135	0.2172	0.9219	0.9219	LDHAL6B/LDHA/NOS3	3
KEGG	hsa05416	Viral myocarditis	2/120	60/8135	0.2216	0.9219	0.9219	RAC3/CD80	2
KEGG	hsa00120	Primary bile acid biosynthesis	1/120	17/8135	0.2234	0.9219	0.9219	CH25H	1
KEGG	hsa04310	Wnt signaling pathway	4/120	167/8135	0.2325	0.9219	0.9219	RAC3/FBXW11/FZD1/WNT10B	4
KEGG	hsa05208	Chemical carcinogenesis - reactive oxygen species	5/120	223/8135	0.2327	0.9219	0.9219	UQCRFS1/GSTM3/SOD1/MAP3K5/NDUFA3	5
KEGG	hsa00511	Other glycan degradation	1/120	18/8135	0.2349	0.9219	0.9219	AGA	1
KEGG	hsa05217	Basal cell carcinoma	2/120	63/8135	0.2379	0.9219	0.9219	FZD1/WNT10B	2
KEGG	hsa04927	Cortisol synthesis and secretion	2/120	65/8135	0.2489	0.9219	0.9219	SCARB1/ORAI1	2
KEGG	hsa04071	Sphingolipid signaling pathway	3/120	119/8135	0.2565	0.9219	0.9219	RAC3/NOS3/MAP3K5	3
KEGG	hsa00100	Steroid biosynthesis	1/120	20/8135	0.2574	0.9219	0.9219	SQLE	1
KEGG	hsa00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	1/120	20/8135	0.2574	0.9219	0.9219	CHST15	1
KEGG	hsa00770	Pantothenate and CoA biosynthesis	1/120	21/8135	0.2684	0.9219	0.9219	ALDH3A2	1
KEGG	hsa04611	Platelet activation	3/120	124/8135	0.2765	0.9219	0.9219	PRKCI/ORAI1/NOS3	3
KEGG	hsa00220	Arginine biosynthesis	1/120	22/8135	0.2792	0.9219	0.9219	NOS3	1
KEGG	hsa00340	Histidine metabolism	1/120	22/8135	0.2792	0.9219	0.9219	ALDH3A2	1
KEGG	hsa00900	Terpenoid backbone biosynthesis	1/120	22/8135	0.2792	0.9219	0.9219	PMVK	1
KEGG	hsa05223	Non-small cell lung cancer	2/120	72/8135	0.2873	0.9219	0.9219	JAK3/RET	2
KEGG	hsa03430	Mismatch repair	1/120	23/8135	0.2898	0.9219	0.9219	MSH2	1
KEGG	hsa00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	1/120	24/8135	0.3003	0.9219	0.9219	EXTL3	1
KEGG	hsa04977	Vitamin digestion and absorption	1/120	24/8135	0.3003	0.9219	0.9219	SCARB1	1
KEGG	hsa05133	Pertussis	2/120	76/8135	0.3092	0.9219	0.9219	SFTPA2/CD14	2
KEGG	hsa00980	Metabolism of xenobiotics by cytochrome P450	2/120	78/8135	0.3201	0.9219	0.9219	GSTM3/HSD11B1L	2
KEGG	hsa04950	Maturity onset diabetes of the young	1/120	26/8135	0.3209	0.9219	0.9219	BHLHA15	1
KEGG	hsa00601	Glycosphingolipid biosynthesis - lacto and neolacto series	1/120	27/8135	0.3309	0.9219	0.9219	GCNT2	1
KEGG	hsa05162	Measles	3/120	139/8135	0.3371	0.9219	0.9219	CD46/JAK3/IRF7	3
KEGG	hsa04146	Peroxisome	2/120	82/8135	0.3418	0.9219	0.9219	SOD1/PMVK	2
KEGG	hsa04662	B cell receptor signaling pathway	2/120	82/8135	0.3418	0.9219	0.9219	RAC3/IFITM1	2
KEGG	hsa04936	Alcoholic liver disease	3/120	142/8135	0.3493	0.9219	0.9219	ALDH3A2/CD14/MAP3K5	3
KEGG	hsa00591	Linoleic acid metabolism	1/120	29/8135	0.3506	0.9219	0.9219	CYP2J2	1
KEGG	hsa05205	Proteoglycans in cancer	4/120	205/8135	0.3582	0.9219	0.9219	GAB1/THBS1/FZD1/WNT10B	4
KEGG	hsa00053	Ascorbate and aldarate metabolism	1/120	30/8135	0.3602	0.9219	0.9219	ALDH3A2	1
KEGG	hsa05210	Colorectal cancer	2/120	86/8135	0.3632	0.9219	0.9219	RAC3/MSH2	2
KEGG	hsa03040	Spliceosome	3/120	147/8135	0.3695	0.9219	0.9219	SF3B5/SNRNP70/LSM5	3
KEGG	hsa05224	Breast cancer	3/120	147/8135	0.3695	0.9219	0.9219	FZD1/WNT10B/HEY2	3
KEGG	hsa00410	beta-Alanine metabolism	1/120	31/8135	0.3697	0.9219	0.9219	ALDH3A2	1
KEGG	hsa04710	Circadian rhythm	1/120	31/8135	0.3697	0.9219	0.9219	FBXW11	1
KEGG	hsa04512	ECM-receptor interaction	2/120	88/8135	0.3738	0.9219	0.9219	THBS1/ITGA3	2
KEGG	hsa04015	Rap1 signaling pathway	4/120	210/8135	0.375	0.9219	0.9219	RAC3/PRKCI/THBS1/RAPGEF6	4
KEGG	hsa05020	Prion disease	5/120	273/8135	0.3765	0.9219	0.9219	PSMA7/TUBB3/UQCRFS1/SOD1/NDUFA3	5
KEGG	hsa05226	Gastric cancer	3/120	149/8135	0.3776	0.9219	0.9219	GAB1/FZD1/WNT10B	3
KEGG	hsa04136	Autophagy - other	1/120	32/8135	0.379	0.9219	0.9219	PIK3C3	1
KEGG	hsa01240	Biosynthesis of cofactors	3/120	153/8135	0.3936	0.9219	0.9219	PPOX/VKORC1L1/ALDH3A2	3
KEGG	hsa04970	Salivary secretion	2/120	93/8135	0.4001	0.9219	0.9219	BST1/AMY2A	2
KEGG	hsa04932	Non-alcoholic fatty liver disease	3/120	155/8135	0.4016	0.9219	0.9219	UQCRFS1/MAP3K5/NDUFA3	3
KEGG	hsa00500	Starch and sucrose metabolism	1/120	36/8135	0.415	0.9219	0.9219	AMY2A	1
KEGG	hsa00512	Mucin type O-glycan biosynthesis	1/120	36/8135	0.415	0.9219	0.9219	GALNT11	1
KEGG	hsa00760	Nicotinate and nicotinamide metabolism	1/120	36/8135	0.415	0.9219	0.9219	BST1	1
KEGG	hsa03030	DNA replication	1/120	36/8135	0.415	0.9219	0.9219	RNASEH2C	1
KEGG	hsa00250	Alanine, aspartate and glutamate metabolism	1/120	37/8135	0.4237	0.9219	0.9219	RIMKLB	1
KEGG	hsa05216	Thyroid cancer	1/120	37/8135	0.4237	0.9219	0.9219	RET	1
KEGG	hsa04750	Inflammatory mediator regulation of TRP channels	2/120	98/8135	0.4258	0.9219	0.9219	TRPV2/CYP2J2	2
KEGG	hsa04925	Aldosterone synthesis and secretion	2/120	98/8135	0.4258	0.9219	0.9219	SCARB1/ORAI1	2
KEGG	hsa05330	Allograft rejection	1/120	38/8135	0.4322	0.9219	0.9219	CD80	1
KEGG	hsa00513	Various types of N-glycan biosynthesis	1/120	39/8135	0.4406	0.9219	0.9219	RPN2	1
KEGG	hsa04916	Melanogenesis	2/120	101/8135	0.441	0.9219	0.9219	FZD1/WNT10B	2
KEGG	hsa04972	Pancreatic secretion	2/120	102/8135	0.446	0.9219	0.9219	BST1/AMY2A	2
KEGG	hsa05168	Herpes simplex virus 1 infection	8/120	495/8135	0.4478	0.9219	0.9219	ZNF461/ZNF30/ZNF808/ZNF596/IRF7/ZNF433/ZNF679/ZNF181	8
KEGG	hsa04714	Thermogenesis	4/120	232/8135	0.4485	0.9219	0.9219	SMARCA2/UQCRFS1/MAP3K5/NDUFA3	4
KEGG	hsa04530	Tight junction	3/120	169/8135	0.4566	0.9219	0.9219	PRKCI/MAP3K5/RAPGEF6	3
KEGG	hsa03440	Homologous recombination	1/120	41/8135	0.4571	0.9219	0.9219	RAD51D	1
KEGG	hsa05219	Bladder cancer	1/120	41/8135	0.4571	0.9219	0.9219	THBS1	1
KEGG	hsa04141	Protein processing in endoplasmic reticulum	3/120	171/8135	0.4643	0.9219	0.9219	RPN2/GANAB/MAP3K5	3
KEGG	hsa05164	Influenza A	3/120	171/8135	0.4643	0.9219	0.9219	IRF7/CALCOCO2/NXT2	3
KEGG	hsa00380	Tryptophan metabolism	1/120	42/8135	0.4651	0.9219	0.9219	ALDH3A2	1
KEGG	hsa05332	Graft-versus-host disease	1/120	42/8135	0.4651	0.9219	0.9219	CD80	1
KEGG	hsa04922	Glucagon signaling pathway	2/120	107/8135	0.4707	0.9219	0.9219	LDHAL6B/LDHA	2
KEGG	hsa00071	Fatty acid degradation	1/120	43/8135	0.4731	0.9219	0.9219	ALDH3A2	1
KEGG	hsa00860	Porphyrin metabolism	1/120	43/8135	0.4731	0.9219	0.9219	PPOX	1
KEGG	hsa04940	Type I diabetes mellitus	1/120	43/8135	0.4731	0.9219	0.9219	CD80	1
KEGG	hsa04975	Fat digestion and absorption	1/120	43/8135	0.4731	0.9219	0.9219	SCARB1	1
KEGG	hsa04740	Olfactory transduction	7/120	440/8135	0.4746	0.9219	0.9219	OR10Q1/OR6V1/OR52W1/OR4D2/OR5T1/OR8J3/OR5M9	7
KEGG	hsa03013	Nucleocytoplasmic transport	2/120	108/8135	0.4755	0.9219	0.9219	NUP62/NXT2	2
KEGG	hsa04931	Insulin resistance	2/120	108/8135	0.4755	0.9219	0.9219	NOS3/NR1H2	2
KEGG	hsa03022	Basal transcription factors	1/120	45/8135	0.4886	0.9219	0.9219	CDK7	1
KEGG	hsa03050	Proteasome	1/120	46/8135	0.4962	0.9219	0.9219	PSMA7	1
KEGG	hsa05152	Tuberculosis	3/120	180/8135	0.4983	0.9219	0.9219	PIK3C3/KSR1/CD14	3
KEGG	hsa00514	Other types of O-glycan biosynthesis	1/120	47/8135	0.5036	0.9219	0.9219	GALNT11	1
KEGG	hsa03420	Nucleotide excision repair	1/120	47/8135	0.5036	0.9219	0.9219	CDK7	1
KEGG	hsa04973	Carbohydrate digestion and absorption	1/120	47/8135	0.5036	0.9219	0.9219	AMY2A	1
KEGG	hsa04360	Axon guidance	3/120	182/8135	0.5057	0.9219	0.9219	RAC3/SEMA4F/L1CAM	3
KEGG	hsa04621	NOD-like receptor signaling pathway	3/120	184/8135	0.5131	0.9219	0.9219	TRPV2/TANK/IRF7	3
KEGG	hsa04672	Intestinal immune network for IgA production	1/120	49/8135	0.5183	0.9219	0.9219	CD80	1
KEGG	hsa05144	Malaria	1/120	50/8135	0.5254	0.9219	0.9219	THBS1	1
KEGG	hsa04722	Neurotrophin signaling pathway	2/120	119/8135	0.5271	0.9219	0.9219	GAB1/MAP3K5	2
KEGG	hsa04062	Chemokine signaling pathway	3/120	192/8135	0.542	0.9219	0.9219	RAC3/JAK3/XCL2	3
KEGG	hsa05202	Transcriptional misregulation in cancer	3/120	193/8135	0.5455	0.9219	0.9219	MLLT1/BCL6/CD14	3
KEGG	hsa05320	Autoimmune thyroid disease	1/120	53/8135	0.5462	0.9219	0.9219	CD80	1
KEGG	hsa05167	Kaposi sarcoma-associated herpesvirus infection	3/120	194/8135	0.549	0.9219	0.9219	ATG14/PIK3C3/IRF7	3
KEGG	hsa04110	Cell cycle	2/120	126/8135	0.5582	0.9219	0.9219	CDK7/ORC1	2
KEGG	hsa04340	Hedgehog signaling pathway	1/120	56/8135	0.5662	0.9219	0.9219	FBXW11	1
KEGG	hsa05134	Legionellosis	1/120	57/8135	0.5726	0.9219	0.9219	CD14	1
KEGG	hsa04510	Focal adhesion	3/120	201/8135	0.5733	0.9219	0.9219	RAC3/THBS1/ITGA3	3
KEGG	hsa05169	Epstein-Barr virus infection	3/120	202/8135	0.5767	0.9219	0.9219	ISG15/JAK3/IRF7	3
KEGG	hsa00480	Glutathione metabolism	1/120	58/8135	0.5789	0.9219	0.9219	GSTM3	1
KEGG	hsa04114	Oocyte meiosis	2/120	131/8135	0.5794	0.9219	0.9219	STAG3/FBXW11	2
KEGG	hsa05415	Diabetic cardiomyopathy	3/120	203/8135	0.58	0.9219	0.9219	UQCRFS1/NOS3/NDUFA3	3
KEGG	hsa04330	Notch signaling pathway	1/120	59/8135	0.5852	0.9219	0.9219	HEY2	1
KEGG	hsa00190	Oxidative phosphorylation	2/120	134/8135	0.5918	0.9219	0.9219	UQCRFS1/NDUFA3	2
KEGG	hsa00140	Steroid hormone biosynthesis	1/120	61/8135	0.5974	0.9219	0.9219	HSD11B1L	1
KEGG	hsa00561	Glycerolipid metabolism	1/120	61/8135	0.5974	0.9219	0.9219	ALDH3A2	1
KEGG	hsa00590	Arachidonic acid metabolism	1/120	61/8135	0.5974	0.9219	0.9219	CYP2J2	1
KEGG	hsa04213	Longevity regulating pathway - multiple species	1/120	62/8135	0.6034	0.9219	0.9219	SOD1	1
KEGG	hsa04151	PI3K-Akt signaling pathway	5/120	354/8135	0.6036	0.9219	0.9219	JAK3/THBS1/TCL1A/NOS3/ITGA3	5
KEGG	hsa00310	Lysine degradation	1/120	63/8135	0.6093	0.9219	0.9219	ALDH3A2	1
KEGG	hsa03250	Viral life cycle - HIV-1	1/120	63/8135	0.6093	0.9219	0.9219	MLLT1	1
KEGG	hsa04623	Cytosolic DNA-sensing pathway	1/120	63/8135	0.6093	0.9219	0.9219	IRF7	1
KEGG	hsa05170	Human immunodeficiency virus 1 infection	3/120	212/8135	0.6097	0.9219	0.9219	RAC3/AP1B1/FBXW11	3
KEGG	hsa04371	Apelin signaling pathway	2/120	139/8135	0.6119	0.9219	0.9219	PIK3C3/NOS3	2
KEGG	hsa04120	Ubiquitin mediated proteolysis	2/120	142/8135	0.6236	0.9219	0.9219	FBXW11/UBE2K	2
KEGG	hsa05221	Acute myeloid leukemia	1/120	67/8135	0.632	0.9219	0.9219	CD14	1
KEGG	hsa00830	Retinol metabolism	1/120	68/8135	0.6375	0.9219	0.9219	RDH16	1
KEGG	hsa04664	Fc epsilon RI signaling pathway	1/120	68/8135	0.6375	0.9219	0.9219	RAC3	1
KEGG	hsa04924	Renin secretion	1/120	69/8135	0.6429	0.9219	0.9219	ORAI1	1
KEGG	hsa05211	Renal cell carcinoma	1/120	69/8135	0.6429	0.9219	0.9219	GAB1	1
KEGG	hsa04514	Cell adhesion molecules	2/120	149/8135	0.6498	0.9219	0.9219	CD80/L1CAM	2
KEGG	hsa04520	Adherens junction	1/120	71/8135	0.6534	0.9219	0.9219	RAC3	1
KEGG	hsa00982	Drug metabolism - cytochrome P450	1/120	72/8135	0.6586	0.9219	0.9219	GSTM3	1
KEGG	hsa04137	Mitophagy - animal	1/120	72/8135	0.6586	0.9219	0.9219	CALCOCO2	1
KEGG	hsa00562	Inositol phosphate metabolism	1/120	73/8135	0.6637	0.9219	0.9219	PIK3C3	1
KEGG	hsa04115	p53 signaling pathway	1/120	73/8135	0.6637	0.9219	0.9219	THBS1	1
KEGG	hsa04014	Ras signaling pathway	3/120	232/8135	0.6705	0.9219	0.9219	GAB1/RAC3/KSR1	3
KEGG	hsa03320	PPAR signaling pathway	1/120	75/8135	0.6736	0.9219	0.9219	ANGPTL4	1
KEGG	hsa04918	Thyroid hormone synthesis	1/120	75/8135	0.6736	0.9219	0.9219	SLC5A5	1
KEGG	hsa04218	Cellular senescence	2/120	156/8135	0.6745	0.9219	0.9219	RAD9A/FBXW11	2
KEGG	hsa05160	Hepatitis C	2/120	157/8135	0.6779	0.9219	0.9219	SCARB1/IRF7	2
KEGG	hsa05212	Pancreatic cancer	1/120	76/8135	0.6785	0.9219	0.9219	RAC3	1
KEGG	hsa05100	Bacterial invasion of epithelial cells	1/120	77/8135	0.6833	0.9219	0.9219	GAB1	1
KEGG	hsa05412	Arrhythmogenic right ventricular cardiomyopathy	1/120	77/8135	0.6833	0.9219	0.9219	ITGA3	1
KEGG	hsa01521	EGFR tyrosine kinase inhibitor resistance	1/120	79/8135	0.6926	0.9219	0.9219	GAB1	1
KEGG	hsa03018	RNA degradation	1/120	79/8135	0.6926	0.9219	0.9219	LSM5	1
KEGG	hsa04020	Calcium signaling pathway	3/120	240/8135	0.6928	0.9219	0.9219	ORAI1/NOS3/RET	3
KEGG	hsa04630	JAK-STAT signaling pathway	2/120	162/8135	0.6946	0.9219	0.9219	JAK3/IFNW1	2
KEGG	hsa05161	Hepatitis B	2/120	162/8135	0.6946	0.9219	0.9219	JAK3/IRF7	2
KEGG	hsa00983	Drug metabolism - other enzymes	1/120	80/8135	0.6972	0.9219	0.9219	GSTM3	1
KEGG	hsa04022	cGMP-PKG signaling pathway	2/120	167/8135	0.7106	0.9219	0.9219	ADRA2B/NOS3	2
KEGG	hsa05132	Salmonella infection	3/120	249/8135	0.7165	0.9219	0.9219	TUBB3/PIK3C3/CD14	3
KEGG	hsa04012	ErbB signaling pathway	1/120	85/8135	0.7191	0.9219	0.9219	GAB1	1
KEGG	hsa04610	Complement and coagulation cascades	1/120	85/8135	0.7191	0.9219	0.9219	CD46	1
KEGG	hsa04260	Cardiac muscle contraction	1/120	87/8135	0.7274	0.9219	0.9219	UQCRFS1	1
KEGG	hsa04540	Gap junction	1/120	88/8135	0.7315	0.9219	0.9219	TUBB3	1
KEGG	hsa04976	Bile secretion	1/120	89/8135	0.7355	0.9219	0.9219	SCARB1	1
KEGG	hsa05410	Hypertrophic cardiomyopathy	1/120	90/8135	0.7394	0.9219	0.9219	ITGA3	1
KEGG	hsa04658	Th1 and Th2 cell differentiation	1/120	92/8135	0.7472	0.9219	0.9219	JAK3	1
KEGG	hsa05222	Small cell lung cancer	1/120	92/8135	0.7472	0.9219	0.9219	ITGA3	1
KEGG	hsa05323	Rheumatoid arthritis	1/120	93/8135	0.7509	0.9219	0.9219	CD80	1
KEGG	hsa05414	Dilated cardiomyopathy	1/120	96/8135	0.7619	0.9219	0.9219	ITGA3	1
KEGG	hsa03015	mRNA surveillance pathway	1/120	97/8135	0.7655	0.9219	0.9219	NXT2	1
KEGG	hsa04070	Phosphatidylinositol signaling system	1/120	97/8135	0.7655	0.9219	0.9219	PIK3C3	1
KEGG	hsa05231	Choline metabolism in cancer	1/120	98/8135	0.769	0.9219	0.9219	RAC3	1
KEGG	hsa04080	Neuroactive ligand-receptor interaction	4/120	353/8135	0.7712	0.9219	0.9219	ADM/CHRND/ADRA2B/DRD4	4
KEGG	hsa04061	Viral protein interaction with cytokine and cytokine receptor	1/120	100/8135	0.7758	0.9219	0.9219	XCL2	1
KEGG	hsa04933	AGE-RAGE signaling pathway in diabetic complications	1/120	100/8135	0.7758	0.9219	0.9219	NOS3	1
KEGG	hsa05146	Amoebiasis	1/120	102/8135	0.7825	0.9219	0.9219	CD14	1
KEGG	hsa04064	NF-kappa B signaling pathway	1/120	104/8135	0.7889	0.9219	0.9219	CD14	1
KEGG	hsa04625	C-type lectin receptor signaling pathway	1/120	104/8135	0.7889	0.9219	0.9219	KSR1	1
KEGG	hsa04660	T cell receptor signaling pathway	1/120	104/8135	0.7889	0.9219	0.9219	TEC	1
KEGG	hsa04659	Th17 cell differentiation	1/120	108/8135	0.8013	0.9219	0.9219	JAK3	1
KEGG	hsa03008	Ribosome biogenesis in eukaryotes	1/120	109/8135	0.8042	0.9219	0.9219	NXT2	1
KEGG	hsa05203	Viral carcinogenesis	2/120	204/8135	0.8082	0.9219	0.9219	JAK3/IRF7	2
KEGG	hsa04668	TNF signaling pathway	1/120	112/8135	0.8129	0.9219	0.9219	MAP3K5	1
KEGG	hsa04010	MAPK signaling pathway	3/120	294/8135	0.8146	0.9219	0.9219	RAC3/CD14/MAP3K5	3
KEGG	hsa04060	Cytokine-cytokine receptor interaction	3/120	295/8135	0.8164	0.9219	0.9219	TNFRSF9/IFNW1/XCL2	3
KEGG	hsa01200	Carbon metabolism	1/120	115/8135	0.8211	0.9219	0.9219	PCCA	1
KEGG	hsa04726	Serotonergic synapse	1/120	115/8135	0.8211	0.9219	0.9219	CYP2J2	1
KEGG	hsa05207	Chemical carcinogenesis - receptor activation	2/120	212/8135	0.825	0.9219	0.9219	GSTM3/BCL6	2
KEGG	hsa04810	Regulation of actin cytoskeleton	2/120	218/8135	0.8368	0.9219	0.9219	RAC3/ITGA3	2
KEGG	hsa04024	cAMP signaling pathway	2/120	221/8135	0.8424	0.9219	0.9219	RAC3/ORAI1	2
KEGG	hsa04380	Osteoclast differentiation	1/120	128/8135	0.853	0.9219	0.9219	TEC	1
KEGG	hsa04926	Relaxin signaling pathway	1/120	129/8135	0.8552	0.9219	0.9219	NOS3	1
KEGG	hsa04068	FoxO signaling pathway	1/120	131/8135	0.8595	0.9219	0.9219	BCL6	1
KEGG	hsa04650	Natural killer cell mediated cytotoxicity	1/120	131/8135	0.8595	0.9219	0.9219	RAC3	1
KEGG	hsa04728	Dopaminergic synapse	1/120	132/8135	0.8616	0.9219	0.9219	DRD4	1
KEGG	hsa04270	Vascular smooth muscle contraction	1/120	134/8135	0.8657	0.9219	0.9219	ADM	1
KEGG	hsa04210	Apoptosis	1/120	136/8135	0.8697	0.9219	0.9219	MAP3K5	1
KEGG	hsa05322	Systemic lupus erythematosus	1/120	136/8135	0.8697	0.9219	0.9219	CD80	1
KEGG	hsa04910	Insulin signaling pathway	1/120	137/8135	0.8717	0.9219	0.9219	PRKCI	1
KEGG	hsa05135	Yersinia infection	1/120	137/8135	0.8717	0.9219	0.9219	RAC3	1
KEGG	hsa04915	Estrogen signaling pathway	1/120	138/8135	0.8736	0.9219	0.9219	NOS3	1
KEGG	hsa04144	Endocytosis	2/120	251/8135	0.8897	0.927	0.927	PRKCI/AGAP3	2
KEGG	hsa04072	Phospholipase D signaling pathway	1/120	148/8135	0.8914	0.927	0.927	GAB1	1
KEGG	hsa04723	Retrograde endocannabinoid signaling	1/120	148/8135	0.8914	0.927	0.927	NDUFA3	1
KEGG	hsa04261	Adrenergic signaling in cardiomyocytes	1/120	150/8135	0.8946	0.927	0.927	CREM	1
KEGG	hsa04921	Oxytocin signaling pathway	1/120	154/8135	0.9008	0.9283	0.9283	NOS3	1
KEGG	hsa03010	Ribosome	1/120	158/8135	0.9066	0.9283	0.9283	MRPS21	1
KEGG	hsa04217	Necroptosis	1/120	159/8135	0.908	0.9283	0.9283	JAK3	1
KEGG	hsa05130	Pathogenic Escherichia coli infection	1/120	197/8135	0.9484	0.9652	0.9652	TUBB3	1
KEGG	hsa05166	Human T-cell leukemia virus 1 infection	1/120	222/8135	0.9647	0.974	0.974	JAK3	1
KEGG	hsa05163	Human cytomegalovirus infection	1/120	225/8135	0.9663	0.974	0.974	RAC3	1
KEGG	hsa05171	Coronavirus disease - COVID-19	1/120	232/8135	0.9697	0.974	0.974	ISG15	1
KEGG	hsa05206	MicroRNAs in cancer	1/120	310/8135	0.9909	0.9909	0.9909	THBS1	1